Study tests combo of heart valve, lower dose of blood thinners

U.S. scientists are conducting an FDA-approved study to test the safety and efficacy of using lower dosages of anti-coagulants in patients with a mechanical heart valve from On-X Life Technologies. The On-X device may become the first heart valve approved for patients taking lower doses of blood-thinning drugs and could help improve quality of life, one of the researchers said.

View Full Article in:

Indianapolis Star (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL